Pedeboscq S - Search Results

1

[Quality assurance in head and neck medical oncology].

Digue L, Pedeboscq S. Digue L, et al. Among authors: pedeboscq s. Bull Cancer. 2014 May 1;101(5):486-95. doi: 10.1684/bdc.2014.1968. Bull Cancer. 2014. PMID: 24886900 Review. French.

2

Chemotherapy and targeted agents for colorectal cancer in a real-life setting anticipate guidelines: the COLCHIC cohort study.

Smith D, Terrebonne E, Rouyer M, Blanc JF, Breilh D, Pedeboscq S, Le Monies A, Lecomte C, Lassalle R, Moore N, Fourrier-Réglat A. Smith D, et al. Among authors: pedeboscq s. Fundam Clin Pharmacol. 2013 Feb;27(1):113-9. doi: 10.1111/j.1472-8206.2011.00961.x. Epub 2011 Jul 27. Fundam Clin Pharmacol. 2013. PMID: 21793898

3

[Survey of the prescriptions of proton pump inhibitors in patients admitted in an internal medicine ward: how is the compliance to the French guidelines?].

Sauvaget L, Rolland L, Dabadie S, Desblaches J, Bernard N, Vandenhende MA, Bonnet F, Pédeboscq S, Morlat P. Sauvaget L, et al. Among authors: pedeboscq s. Rev Med Interne. 2015 Oct;36(10):651-7. doi: 10.1016/j.revmed.2015.04.014. Epub 2015 Jun 4. Rev Med Interne. 2015. PMID: 26051189 French.

4

Proper use of carbapenems: Role of the infectious disease specialist.

Issa N, Pedeboscq S, Le Quellec F, Bessède E, Vandenhende M, Bonnet F, Morlat P, Camou F. Issa N, et al. Among authors: pedeboscq s. Med Mal Infect. 2016 Feb;46(1):10-3. doi: 10.1016/j.medmal.2015.11.008. Epub 2015 Dec 14. Med Mal Infect. 2016. PMID: 26698014

5

Avdoralimab (Anti-C5aR1 mAb) Versus Placebo in Patients With Severe COVID-19: Results From a Randomized Controlled Trial (FOR COVID Elimination [FORCE]).

Carvelli J, Meziani F, Dellamonica J, Cordier PY, Allardet-Servent J, Fraisse M, Velly L, Barbar SD, Lehingue S, Guervilly C, Desgrouas M, Camou F, Piperoglou C, Vely F, Demaria O, Karakunnel J, Fares J, Batista L, Rotolo F, Viotti J, Boyer-Chammard A, Lacombe K, Le Dault E, Carles M, Schleinitz N, Vivier E; FOR COVID Elimination (FORCE) Study Group. Carvelli J, et al. Crit Care Med. 2022 Dec 1;50(12):1788-1798. doi: 10.1097/CCM.0000000000005683. Epub 2022 Oct 10. Crit Care Med. 2022. PMID: 36218354 Free PMC article. Clinical Trial.

6

Impact of a 5-year antimicrobial stewardship program focusing on fluoroquinolone prescriptions.

Pédeboscq S, Issa N, Lahouati M, Labadie A, Pereyre S, Camou F. Pédeboscq S, et al. Int J Pharm Pract. 2021 Dec 4;29(6):616-621. doi: 10.1093/ijpp/riab047. Int J Pharm Pract. 2021. PMID: 34355739

7

[Proper use of antibiotics: a prospective study on the use of linezolid in a French university hospital].

Duhalde V, Lahille B, Camou F, Pédeboscq S, Pometan JP. Duhalde V, et al. Among authors: pedeboscq s. Pathol Biol (Paris). 2007 Dec;55(10):478-81. doi: 10.1016/j.patbio.2007.07.018. Epub 2007 Sep 27. Pathol Biol (Paris). 2007. PMID: 17904310 French.

8

Synthesis and evaluation of apoptosis induction of thienopyrimidine compounds on KRAS and BRAF mutated colorectal cancer cell lines.

Pédeboscq S, Gravier D, Casadebaig F, Hou G, Gissot A, Rey C, Ichas F, De Giorgi F, Lartigue L, Pometan JP. Pédeboscq S, et al. Bioorg Med Chem. 2012 Nov 15;20(22):6724-31. doi: 10.1016/j.bmc.2012.09.034. Epub 2012 Sep 24. Bioorg Med Chem. 2012. PMID: 23063521

9

A multicenter prospective observational study of the conformity of temozolomide prescriptions in France.

Tilleul P, Brignone M, Hassani Y, Labrande C, Pedeboscq S, Gensollen S, Lahille B, Exinger D, Bertholle V, Billard M, Charlety D, Prebay D, Pinguet F, Taillibert S, Cartalat S, Chinot O, Borget I; Temozolomide Study Group of Société Française de Pharmacie Oncologique. Tilleul P, et al. Among authors: pedeboscq s. Pharmacoepidemiol Drug Saf. 2012 Aug;21(8):828-34. doi: 10.1002/pds.3233. Epub 2012 Mar 15. Pharmacoepidemiol Drug Saf. 2012. PMID: 22419509

10

Pulmonary granuloma, polyarthritis and antiphospholipids in common variable immunodeficiency: resolution after IVIG and the role of immunoglobulin A.

Bonnet F, Morlat P, Viallard JF, Pédeboscq S, De Witte S, Beylot J. Bonnet F, et al. Among authors: pedeboscq s. Clin Exp Rheumatol. 2005 May-Jun;23(3):428-9. Clin Exp Rheumatol. 2005. PMID: 15971440 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters